3IC Stock Chart & Stats
€18.73
€0.22(1.16%)
At close: 4:00 PM EDT
€18.73
€0.22(1.16%)
Day’s Range― - ―
52-Week Range€14.33 - €22.34
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.09B
Enterprise Value€4.68B
Total Cash (Recent Filing)€794.70M
Total Debt (Recent Filing)€4.00B
Price to Earnings (P/E)―
Beta0.45
Next Earnings
Feb 22, 2027EPS Estimate
1.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.47
Shares Outstanding76,234,540
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.43
Price to Sales (P/S)1.15
P/FCF Ratio-327.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€19.35Price Target Upside3.31% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)2.92
Revenue Forecast (FY)€299.28M
Bulls Say, Bears Say
Bulls Say
Healthcare Real Estate IncomeHealthcare properties leased to clinics, hospitals, and other operators can provide recurring rental income with greater visibility than shorter-cycle development revenue. This portfolio component supports business resilience and helps diversify Icade’s exposure across real estate segments over the next several quarters.
Positive Operating Cash FlowPositive operating cash flow in every reported year indicates that Icade’s core property and operating activities continue to generate cash, despite weaker profitability. This recurring cash generation can support interest payments, property operations, and selective investment through varying real estate conditions.
Improved LeverageLeverage has improved from the 2022 peak and remains described as meaningful but not extreme for a diversified REIT. This provides a more serviceable capital structure than at the earlier high point, preserving some capacity to manage assets and fund operations over the medium term.
Bears Say
Persistent Net LossesThree consecutive years of net losses and continued negative margins show that reported earnings remain structurally weak rather than temporarily disrupted. Sustained losses can reduce capital strength, constrain reinvestment, and make it harder for the company to convert its property base into dependable shareholder returns.
Inconsistent Free Cash FlowFree cash flow has repeatedly turned negative after investment and other cash needs, including the latest reported year. This stop-start cash profile limits financial flexibility, increases reliance on asset sales or financing for funding needs, and weakens confidence that operating cash consistently supports long-term capital allocation.
Weak Revenue TrendBroadly stagnant or declining revenue indicates limited top-line momentum across Icade’s property and development activities. The modest 2025 rebound does not yet demonstrate a durable growth trend, which can restrict operating leverage and make it more difficult to rebuild profitability while costs and capital needs persist.
Icade SA News
3IC FAQ
What was Icade SA’s price range in the past 12 months?
Icade SA lowest stock price was €14.33 and its highest was €22.34 in the past 12 months.
What is Icade SA’s market cap?
Icade SA’s market cap is €1.09B.
When is Icade SA’s upcoming earnings report date?
Icade SA’s upcoming earnings report date is Feb 22, 2027 which is in 124 days.
How were Icade SA’s earnings last quarter?
Icade SA released its earnings results on Jul 21, 2026. The company reported €1.161 earnings per share for the quarter, missing the consensus estimate of €1.24 by -€0.079.
Is Icade SA overvalued?
According to Wall Street analysts Icade SA’s price is currently Undervalued.
Does Icade SA pay dividends?
Icade SA does not currently pay dividends.
What is Icade SA’s EPS estimate?
Icade SA’s EPS estimate is 1.26.
How many shares outstanding does Icade SA have?
Icade SA has 76,234,540 shares outstanding.
What happened to Icade SA’s price movement after its last earnings report?
Icade SA reported an EPS of €1.161 in its last earnings report, missing expectations of €1.24. Following the earnings report the stock price went down -0.052%.
Which hedge fund is a major shareholder of Icade SA?
Currently, no hedge funds are holding shares in DE:3IC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Icade SA
Icade functions as a comprehensive real estate entity, actively investing in and developing properties. It specializes in crafting innovative real estate solutions and offerings tailored to evolving urban lifestyles and demands. With corporate social responsibility and innovation central to its strategic approach, Icade cultivates close relationships with a broad spectrum of urban stakeholders, including local governments, communities, businesses, their employees, and various institutions and associations. The company is a significant investor in office and healthcare properties, possessing a portfolio valued at €11.6 billion (as of June 30, 2020, on a proportionate consolidation basis), and also operates as a robust property developer, generating nearly €1 billion in economic revenues in 2019. Through these endeavors, Icade has redefined the real estate sector, championing the emergence of tomorrow's greener, smarter, and more responsible urban environments. Its operations are particularly prominent across the Greater Paris region and other major French cities. Icade is publicly traded on Euronext Paris as a French Listed Real Estate Investment Company (société d'investissement immobilier cotée, SIIC), and its primary shareholder is the Caisse des dépôts Group.
3IC Stock 12 Month Forecast
Average Price Target
€19.35
▲(3.31% Upside)